Milestone Pharmaceuticals MIST
NASDAQ MIST
$1.05 -0.02 (-1.87%)
At close: Sep 10, 2026 · 4:00 PM EDT

Milestone Pharmaceuticals (MIST) Tax Provisions (2018 - 2020)

Milestone Pharmaceuticals' (MIST) quarterly Tax Provisions came in at -$17000.0 in Q3 2020, up 76.71% on a YoY basis from -$9620.2 in Q4 2019, and down 1600.0% quarter-over-quarter from -$1000.0 in Q4 2019.

Analysis

Milestone Pharmaceuticals (MIST) Tax Provisions (2018 - 2020) Analysis & Trends

Milestone Pharmaceuticals (MIST) has reported Tax Provisions for 3 consecutive years, with -$17000.0 the latest figure, recorded in Q3 2020.

  • For the quarter ending Q3 2020, Tax Provisions rose 76.71% year-over-year to -$17000.0; the trailing twelve-month figure through Dec 2020 stood at -$91000.0 (down 62.5% YoY), and the FY2020 full-year result was -$17000.0, up 69.64% from the prior year.
  • Tax Provisions fell to -$17000.0 in Q3 2020 per MIST's latest filing, from -$1000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $56000.0 in Q4 2018 and bottomed at -$73000.0 in Q3 2019.
  • Historically, Tax Provisions has averaged $125.0 across 3 years, with a median of $500.0 in 2018.
  • The sharpest annual moves came in 2019 and 2020: Tax Provisions slumped 300.0% in 2019, then soared 76.71% in 2020.
  • Over 3 years, Tax Provisions stood at $56000.0 in 2018, then slumped by 101.79% to -$1000.0 in 2019, then tumbled by 1600.0% to -$17000.0 in 2020.
  • According to Business Quant data, Tax Provisions over the past three periods registered -$17000.0, -$1000.0, and -$73000.0 for Q3 2020, Q4 2019, and Q3 2019 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 393.00 Mn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 242.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 292.00 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 230.90 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -59.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 15.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 13.31 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 34.90 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -3.96 Mn
10 Milestone Pharmaceuticals 146.32 Mn -25.18 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 -17,000.00
Dec 31, 2019 -1,000.00
Sep 30, 2019 -73,000.00
Jun 30, 2019 -4,000.00
Mar 31, 2019 22,000.00
Dec 31, 2018 56,000.00
Jun 30, 2018 2,000.00
Mar 31, 2018 16,000.00